Downregulation of cAMP response element-binding protein by lentiviral vector-mediated RNAi attenuates morphine withdrawal syndromes in rats

Behavioural Brain Research
Qiang WuKewen Zhou

Abstract

cAMP response element-binding protein(CREB) and the cAMP cascade play a pivotal role in the opiate-dependence. The blockade of this cascade is believed to attenuate signs of physical opiate withdrawal. A lentiviral vector (LV) expressing a small hairpin RNA (shRNA) to silence CREB in vitro and in vivo was used in this study. The effect of the shRNA on the regulation of the relevant protein expression and the signs of opiate withdrawal were subsequently evaluated in rats undergoing chronic morphine treatment. In cultured primary locus coeruleus (LC) neurons, the designed lentiviral vectors were successfully infected into the cells and led to 70% knockdown in CREB expression. In cells treated with chronic morphine, the expression of CREB, adenylyl cyclase (AC) and protein kinase A (PKA) were increased, while in cells infected with LV-CREB3, treated with chronic morphine treatment failed to increase the expressions of CREB and AC. Consistently, in the rat model for chronic morphine treatment, morphine increased the expression of CREB, AC and PKA in LC neurons. However, in rats received bilateral microinjections of LV-CREB3 into the LC, morphine did not alter the levels of these proteins. Moreover, microinjection of LV-CREB3 signif...Continue Reading

References

Apr 1, 1996·Current Opinion in Neurobiology·J C Yin, T Tully
Oct 6, 1997·Science·E J Nestler, G K Aghajanian
Jan 22, 2000·Brain Research Bulletin·A J Silva, G G Murphy
Apr 25, 2000·Brain Research. Developmental Brain Research·B M KivellJ H Miller
Feb 27, 2001·Brain Research. Brain Research Protocols·B M KivellJ H Miller
Jul 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·G FábiánM Szücs
Aug 8, 2002·Proceedings of the National Academy of Sciences of the United States of America·Michel BarrotEric J Nestler
Jan 31, 2003·Synapse·Tamara Z Shaw-LutchmanEric J Nestler
Nov 19, 2003·Journal of Neurochemistry·Carrie L WaltersJulie A Blendy
Apr 6, 2004·Trends in Pharmacological Sciences·Eric J Nestler
Oct 7, 2004·Neuropharmacology·Gary Aston-Jones, Glenda C Harris
Jun 10, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Valerie G OlsonEric J Nestler
Jun 25, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Colleen A McClungVenetia Zachariou
Apr 28, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ming-Hu HanEric J Nestler
Jan 8, 2009·Physiological Reviews·Cristina M Alberini
Mar 10, 2009·Journal of Cellular and Molecular Medicine·Tomie MuraokaToshihiko Ishida
Mar 20, 2009·Journal of Separation Science·Anna Bodzon-KulakowskaJerzy Silberring
Sep 15, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jun-Li CaoMing-Hu Han
Mar 14, 2014·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Mingkwan GreenwoodDavid Murphy

❮ Previous
Next ❯

Citations

Sep 30, 2014·Peptides·Richard J Bodnar
Apr 9, 2016·European Journal of Pharmacology·García-Pardo María PilarAguilar María Asunción
Mar 31, 2021·Experimental Neurology·Tao WangShuanglin Hao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.